NCT01513759 - Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

June 7, 2012

Primary Completion Date

February 17, 2013

Study Completion Date

February 17, 2013

Conditions

Pulmonary EmbolismAcute Pulmonary EmbolismSub-massive Pulmonary EmbolismMassive Pulmonary EmbolismPulmonary Thromboembolism

Interventions

DRUG

recombinant tissue plasminogen activator

Participants will receive 24 mg of r-tPA delivered via the EkoSonic Endovascular Device.

DEVICE

EKOS EkoSonic Endovascular System

24 mg of r-tPA will be delivered through the EkoSonic Endovascular System.

Trial Locations (22)

10467

Montefiore Medical Center, The Bronx

19718

Christiana Hospital, Newark

22304

Inova Alexandria Hospital, Alexandria

31201

Medical Center of Central Georgia, Macon

32803

Florida Hospital, Orlando

32806

Orlando Regional Medical Center, Orlando

32901

Holmes Regional Medical Center, Melbourne

33805

Lakeland Regional Medical Center, Lakeland

36116

Baptist Health, Montgomery

40536

University of Kentucky, Gill Heart Institute, Lexington

43213

Mt. Carmel East, Columbus

62701

Prairie Heart Institute, Springfield

70006

East Jefferson General Hospital, New Orleans

79902

Providence Memorial and Sierra Medical Center, El Paso

94305

Stanford University Medical Center, Stanford

95355

Memorial Medical Center, Modesto

Unknown

Hartford Hospital, Hartford

St. Vincent Hospital, Indianapolis

07601

Hackensack University Medical Center, Hackensack

07960

Overlook Medical Center, Morristown

07666

Holy Name Hospital, Teaneck

02906

The Miriam Hospital, Providence